Time line access - Timeline

Brazil starts offering universal free ARV treatment to PLHIV

Brazil starts granting pharmaceutical product patents

MSF launches its international Campaign for Access to Essential Medicines

MSF, Health Action International and Consumer Project on Technology organise the first meeting on compulsory licensing of AIDS medicines, held at the UN (Geneva)

US President Clinton issues Executive Order supporting sub-Saharan African countries in using measures such as compulsory licensing to allow production and import of generic AIDS drugs, without fear of trade retaliation

Multinational drug companies announce price reductions for AIDS drugs

The Fourth WTO Ministerial Conference adopts the Doha Declaration on TRIPS and Public Health

Cipla, announces triple-ARV AIDS treatment for US$ 350 per patient per year

WHO includes ARV medicines in its Essential Medicines List for the first time

WHO starts the “3 by 5” initiative

Thailand offers universal access to ARVs to PLHIV

WTO adopts the ‘August 30th’ decision to allow drugs to be produced under a compulsory licence

UN Secretary-General establishes a High-Level Panel on Access to Medicines

Generic sofosbuvir US$ 10 a pill (Incepta Pharmaceuticals in Bangladesh)

India rejects sofosbuvir patent application by Gilead

UNITAID establishes the Medicines Patent Pool (MPP)

GSK withdrawal its patents and patent applications for AZT/3TC

Establishment of UNITAID